PDCD4 functions as a suppressor for pT2a and pT2b stage gastric cancer

Peng-Tao Guo, Huimian Xu(First Hospital of China Medical University)

Oncology Reports

January 11, 2013

10.3892/or.2013.2232

Cited by 15

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

|Cancer Communications|2021|657

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

TBX2 overexpression promotes proliferation and invasion through epithelial‑mesenchymal transition and ERK signaling pathway

|Experimental and Therapeutic Medicine|2018|19

Hepatitis B virus X protein plays an important role in gastric ulcers

|Oncology Reports|2012|9